Update on Diabetic Disease
Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.
By
Diana V. Do, MD
May 1, 2026
Clinical Scorecard: Update on Diabetic Disease
At a Glance
Category Detail
Condition Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME) Key Mechanisms Vision-threatening complications due to diabetes affecting retinal health. Target Population Patients with diabetes, particularly those exhibiting signs of diabetic retinopathy. Care Setting Ophthalmology clinics, particularly those specializing in retinal diseases.
Key Highlights
30% of evaluated patients had diabetic retinopathy. Latest anti-VEGF treatments include faricimab and aflibercept 8 mg. Artificial intelligence is being utilized for DR screening. Importance of accurate ICD-10 coding for diabetic eye disease. Clinical trials are ongoing for innovative treatments like the PRIMA implant. Guideline-Based Recommendations
Diagnosis
Utilize retina imaging biomarkers for treatment selection in DME. Implement AI for screening to enhance detection rates. Management
Consider anti-VEGF therapies for managing DR and DME. Incorporate corticosteroids based on patient selection and dosing strategies. Monitoring & Follow-up
Regular follow-up for patients with diabetic retinopathy to assess progression. Monitor treatment response using imaging techniques. Risks
Potential complications from new treatments like the PRIMA implant. Risks associated with corticosteroid use in DME management. Patient & Prescribing Data
Diabetic patients at risk for vision loss due to DR and DME.
Focus on personalized treatment plans based on individual patient needs and response.
Clinical Best Practices
Ensure accurate documentation for ICD-10 coding to reflect care complexity. Stay updated on clinical trials for emerging therapies. Related Resources & Content
